Literature DB >> 31297641

Optimized Renal Transporter Quantification by Using Aquaporin 1 and Aquaporin 2 as Anatomical Markers: Application in Characterizing the Ontogeny of Renal Transporters and Its Correlation with Hepatic Transporters in Paired Human Samples.

Cindy Yanfei Li1, Chelsea Hosey-Cojocari2, Abdul Basit1, Jashvant D Unadkat1, J Steven Leeder2, Bhagwat Prasad3.   

Abstract

Renal transporters, which are primarily located in the proximal tubules, play an important role in secretion and nephrotoxicity of drugs. The goal of this study was to characterize the age-dependent protein abundance of human renal transporters. A total of 43 human kidneys, 26 of which were paired with livers from the same donors, were obtained and classified into three age groups: children (< 12 years), adolescents (12 to < 18 years), and adults (> 18 years). Protein abundance of kidney-specific anatomical markers, aquaporins 1 and 2 (markers of proximal and distal/collecting tubules, respectively), and 17 transporters was quantified by LC-MS/MS proteomics. Six out of 43 kidney samples were identified as outliers (Grubbs' test) that were significantly different from the others with relatively higher aquaporin 2 to aquaporin 1 ratio, indicating that these cortex samples were likely contaminated by medulla (representing distal/collecting tubules). No significant age-related changes (age > 1 year) were observed for renal transporter abundance, albeit OCT2 abundance was modestly higher (< 50%) in adolescents than that in adults. Higher protein-protein correlation between transporters was observed in the kidney but abundance of transporters between tissues was not correlated. The use of aquaporins 1 and 2 provides a method for identifying kidney cortex with significant contamination from medulla containing distal and collecting tubules. The abundance and protein-protein correlation data can be used in physiologically based pharmacokinetic (PBPK) modeling and simulation of renal drug disposition and clearance in pediatric populations.

Entities:  

Keywords:  kidney; liver; ontogeny; paired samples; quantitative proteomics; renal transporters

Year:  2019        PMID: 31297641     DOI: 10.1208/s12248-019-0359-1

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  26 in total

1.  Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels.

Authors:  A L Slitt; N J Cherrington; D P Hartley; T M Leazer; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2002-02       Impact factor: 3.922

2.  Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.

Authors:  Bhagwat Prasad; Raymond Evers; Anshul Gupta; Cornelis E C A Hop; Laurent Salphati; Suneet Shukla; Suresh V Ambudkar; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2013-10-11       Impact factor: 3.922

3.  Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice.

Authors:  Jonathan M Maher; Angela L Slitt; Nathan J Cherrington; Xingguo Cheng; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-03-31       Impact factor: 3.922

4.  Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.

Authors:  Maki Nomura; Hideyuki Motohashi; Hiroko Sekine; Toshiya Katsura; Ken-ichi Inui
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-14

5.  Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Authors:  Sumio Ohtsuki; Olaf Schaefer; Hirotaka Kawakami; Tae Inoue; Stephanie Liehner; Asami Saito; Naoki Ishiguro; Wataru Kishimoto; Eva Ludwig-Schwellinger; Thomas Ebner; Tetsuya Terasaki
Journal:  Drug Metab Dispos       Date:  2011-10-12       Impact factor: 3.922

6.  Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney.

Authors:  N Nakajima; T Sekine; S H Cha; A Tojo; M Hosoyamada; Y Kanai; K Yan; S Awa; H Endou
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

7.  Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.

Authors:  K K Filipski; R H Mathijssen; T S Mikkelsen; A H Schinkel; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2009-07-22       Impact factor: 6.875

8.  Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype.

Authors:  Bhagwat Prasad; Yurong Lai; Yvonne Lin; Jashvant D Unadkat
Journal:  J Pharm Sci       Date:  2013-01-01       Impact factor: 3.534

9.  Evaluation of renal function in neonatal rats.

Authors:  R J Kavlock; J A Gray
Journal:  Biol Neonate       Date:  1982

10.  The Importance of Incorporating OCT2 Plasma Membrane Expression and Membrane Potential in IVIVE of Metformin Renal Secretory Clearance.

Authors:  Vineet Kumar; Jia Yin; Sarah Billington; Bhagwat Prasad; Colin D A Brown; Joanne Wang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

View more
  17 in total

Review 1.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

2.  Emerging Roles of the Human Solute Carrier 22 Family.

Authors:  Sook Wah Yee; Kathleen M Giacomini
Journal:  Drug Metab Dispos       Date:  2021-12-17       Impact factor: 3.579

3.  Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7-18 Years.

Authors:  Haeyoung Zhang; Abdul Basit; Chris Wolford; Kuan-Fu Chen; Andrea Gaedigk; Yvonne S Lin; J Steven Leeder; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2020-02-12       Impact factor: 6.875

Review 4.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

5.  Interindividual Variability and Differential Tissue Abundance of Mitochondrial Amidoxime Reducing Component Enzymes in Humans.

Authors:  Deepak Ahire; Abdul Basit; Lisa J Christopher; Ramaswamy Iyer; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2021-12-23       Impact factor: 3.922

6.  In Vivo-to-In Vitro Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach.

Authors:  Aditya R Kumar; Bhagwat Prasad; Deepak Kumar Bhatt; Sumathy Mathialagan; Manthena V S Varma; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2021-04-06       Impact factor: 3.579

7.  Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS.

Authors:  Deepak Suresh Ahire; Abdul Basit; Matthew Karasu; Bhagwat Prasad
Journal:  J Pharm Sci       Date:  2021-03-28       Impact factor: 3.784

8.  Development and application of a pediatric mechanistic kidney model.

Authors:  Farzaneh Salem; Ben G Small; Trevor N Johnson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-04

9.  Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys.

Authors:  Stefan Oswald; Janett Müller; Ute Neugebauer; Rita Schröter; Edwin Herrmann; Hermann Pavenstädt; Giuliano Ciarimboli
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

10.  Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.

Authors:  Zubida M Al-Majdoub; Brahim Achour; Narciso Couto; Martyn Howard; Yasmine Elmorsi; Daniel Scotcher; Sarah Alrubia; Eman El-Khateeb; Areti-Maria Vasilogianni; Noura Alohali; Sibylle Neuhoff; Lutz Schmitt; Amin Rostami-Hodjegan; Jill Barber
Journal:  FEBS Lett       Date:  2020-12-03       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.